Vladimir V Kalinichenko Selected Research

Phenobarbital (Luminal)

1/2007	A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
4/2004	Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir V Kalinichenko Research Topics

Disease

25	Neoplasms (Cancer) 04/2024 - 01/2003
9	Pneumonia (Pneumonitis) 01/2023 - 10/2008
7	Persistent Fetal Circulation Syndrome 01/2023 - 09/2014
7	Carcinogenesis 01/2021 - 02/2005
6	Lung Injury 01/2023 - 06/2002
6	Fibrosis (Cirrhosis) 01/2020 - 01/2012
5	Lung Diseases (Lung Disease) 01/2023 - 07/2011
4	Rhabdomyosarcoma 01/2023 - 01/2017
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 01/2013
4	Hypertrophy 01/2021 - 01/2003
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2004
3	Lung Neoplasms (Lung Cancer) 04/2024 - 02/2006
3	Hyperoxia 01/2023 - 05/2015
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 07/2011
3	Inflammation (Inflammations) 01/2022 - 05/2015
3	Liver Neoplasms (Liver Cancer) 01/2017 - 06/2005
2	Pulmonary Hypertension 03/2024 - 02/2024
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2023 - 09/2014
2	Hyperplasia 01/2023 - 11/2010
2	Idiopathic Pulmonary Fibrosis 01/2023 - 04/2018
2	Metaplasia 04/2017 - 01/2013
2	Chromosomal Instability (Chromosome Stability) 01/2017 - 01/2016
2	Adenocarcinoma 10/2016 - 02/2006
2	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 02/2006
2	Adenocarcinoma of Lung 08/2009 - 02/2006
2	Osteosarcoma (Osteogenic Sarcoma) 07/2008 - 04/2004
2	Hemorrhage 03/2004 - 06/2002
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Chorioamnionitis 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Tracheomalacia 12/2020
1	Rare Diseases (Rare Disease) 09/2020
1	Bronchopulmonary Dysplasia 01/2020
1	Rheumatoid Arthritis 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2019
1	Premature Birth (Birth, Premature) 01/2018
1	Obesity 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2017
1	Adenoma (Adenomas) 12/2017

Drug/Important Bio-Agent (IBA)

30	Transcription Factors (Transcription Factor)IBA 01/2023 - 03/2004
12	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2002
6	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2015
6	Messenger RNA (mRNA)IBA 01/2023 - 06/2002
5	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2023 - 01/2011
4	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 03/2014
4	CollagenIBA 01/2023 - 04/2018
4	AllergensIBA 01/2019 - 10/2008
4	Forkhead Box Protein M1IBA 01/2019 - 02/2006
4	Urethane (Ethyl Carbamate)IBA 12/2017 - 02/2006
4	Butylated Hydroxytoluene (BHT)IBA 08/2009 - 06/2002
3	CateninsIBA 04/2024 - 01/2019
3	Complementary DNA (cDNA)IBA 04/2024 - 01/2021
3	AgarIBA 02/2006 - 04/2004
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2023
2	ChromatinIBA 01/2023 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 10/2021
2	CytokinesIBA 01/2022 - 04/2017
2	Thiostrepton (Gargon)IBA 12/2019 - 01/2017
2	Cyclin D1IBA 01/2017 - 01/2011
2	Cyclin B1IBA 09/2014 - 09/2006
2	Peptides (Polypeptides)IBA 01/2007 - 02/2005
2	Phenobarbital (Luminal)FDA Link 01/2007 - 04/2004
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2007 - 04/2004
2	CarcinogensIBA 01/2007 - 02/2006
1	Drug CombinationsIBA 02/2024
1	Fatty Acid-Binding ProteinsIBA 02/2024
1	NucleotidesIBA 01/2023
1	EstersIBA 01/2023
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2023
1	indium-bleomycinIBA 01/2023
1	TransposasesIBA 01/2023
1	matrigelIBA 01/2023
1	5-(4-nitrophenyl)-2-furoic acid (NPFA)IBA 01/2023
1	tdTomatoIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Transcription Activator-Like Effector NucleasesIBA 09/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2019
1	alpha2 Subunit Collagen Type IIBA 02/2019
1	Cadherins (E-Cadherin)IBA 04/2018
1	TeratogensIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Insulin (Novolin)FDA Link 12/2017
1	MucinsIBA 12/2017
1	Potassium Iodide (Pima)FDA Link 12/2017

Therapy/Procedure

16	Therapeutics 02/2024 - 04/2004
2	Transplantation 01/2024 - 01/2023
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2021
2	Intravenous Administration 01/2023 - 01/2023
1	Cell Transplantation 01/2021
1	Critical Care (Surgical Intensive Care) 01/2020
1	Vagotomy 12/2017